EC chi hơn 70 triệu USD mua thuốc remdesivir điều trị COVID-19
Nhằm đáp ứng nhu cầu cấp bách hiện nay cho các bệnh nhân mắc dịch viêm đường hô hấp cấp COVID-19 ở châu Âu, ngày 29/7, Ủy ban châu Âu (EC) thông báo đã đồng ý mua thuốc kháng virus remdesivir vốn khan hiếm của công ty dược phẩm Mỹ Gilead Sciences.
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
Bình luận
Xin vui lòng gõ tiếng Việt có dấu